Effects of two different circovirus type 2 and Mycoplasma Hyopneumoniae vaccination protocols on acute phase proteins in piglets
Published:August 31, 2026
Source :I. Hernandez 1*, J. A. Lopez 2, S. Figueras 3, V. Rodriguez 4, J. Ceron 5, D. Escribano 5 / 1 Swine advisor, Boehringer-Ingelheim Spain, 2 Veterinarian, Casas Nuevas S.A., Murcia, 3 Swine advisor, Boehringer-Ingelheim Spain, Valencia, 4 Swine advisor, Boehringer-Ingelheim Spain, Leon, 5 Interdisciplinary Laboratory of Clinical Analysis, University of Murcia, Murcia, Spain.
Summary
Keywords: acute phase proteins after vaccination, PCV2-Mycoplasma
Introduction:
Vaccination against Circovirus type 2 (PCV2) and Mycoplasma Hyopneumoniae (M.Hyo) are applied round weaning. This is a critical period for this reason is very important applying vaccines that do not hinder adaptation to this new situation. The acute phase proteins (APPs) in serum have been proposed as suitable veterinary biomarkers to monitor the stress and the inflammatory response, which makes APPs notable parameters for the global assessment of pig welfare. The aim of this study was to evaluate the welfare to vaccination after the application of two different vaccination protocols, against PCV2 and M.Hyo, through of measurement of rectal temperature and two APPs; haptoglobin (Hp) and C-reactive protein (CRP).
Materials and Methods:
In this study, forty piglets Pietrain x (Landrace x Large White) crossbred, of 3.5 weeks of age, from a farm located in South-Eastern Spain, were used. The animals were divided in two groups of 20 animals (10 females and 10 males). The group A was vaccinated with 1 mL of CircoFLEX® and with 1 mL of MycoFLEX® in a single injection of 2 mL (FLEXcombo®; Boehringer Ingelheim, Spain, SA). The group B was vaccinated with Porcilis PCV® (Intervet International, The Netherlands) and Stellamune Mycoplasma® (Elanco Animal Heath, Spain) in two injections of 2mls each. Blood samples were taken before vaccination (baseline), 24 h post-vaccination (Post-V) and 48 h Post-V. Body temperature was measured before vaccination (baseline) and 8 h Post-V. The levels of Hp and CRP were measured using an automated biochemistry analyser (Olympus 2700, Germany). The statistical analyses were performed using GraphPad Prism 6 (Graph Pad, Sowfware, USA). A two-ways ANOVA test was performed and a value of P< 0.05 was used to indicate significance.
Results:
After 8 h Post-V, group B showed evidence of pyrexia relative to baseline (P< 0.001) and rectal temperature levels in group B (40.6 ºC) were significantly greater compared to group A (39.7 ºC). The interaction between type of vaccination and day of sampling was significant for serum Hp and CRP. Group B had elevated concentration of Hp relative to baseline at 24 h Post-V and 48 h Post-V (P< 0.001). Relative to baseline CRP concentration in group B were greater 24 h Post-V. Group B had significantly greater serum CRP concentrations compared to group A (P< 0.001).
Conclusion:
The lesser body temperature and production of APPs with FLEXcombo® contribute to welfare and may be facilitate the adaptation of piglets in this critical period. This enhanced adaptability of piglets vaccinated with CircoFLEX® and MycoFLEX® also have been showed in other trials.
Disclosure of Interest: None Declared.
Published in the proceedings of the International Pig Veterinary Society Congress – IPVS2016. For information on the event, past and future editions, check out https://www.theipvs.com/future-congresses/.